ESC 365 - Impact of medical therapy on balloon pulmonary angioplasty outcomes in chronic thromboembolic pulmonary hypertension

ESC2025 Premium Access

Impact of medical therapy on balloon pulmonary angioplasty outcomes in chronic thromboembolic pulmonary hypertension

Session: Chronic thromboembolic pulmonary hypertension: management strategies

Topic: Pulmonary Hypertension

Speaker: Doctor L. Alajbegovic (Vienna, AT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Leila Alajbegovic

Medical University of Vienna, Vienna (Austria)

0 follower

5 more presentations in this session

Medical therapy for non-operable chronic thromboembolic pulmonary hypertension before and after balloon pulmonary angioplasty: CTEPH AC registry across Japan

Speaker: Doctor Y. Taniguchi (Kobe, JP)

Experience of nine years of balloon pulmonary angioplasty in a single centre: short term results

Speaker: Doctor M. Salvi (Bologna, IT)

Post-pulmonary endarterectomy hemodynamic changes evaluated by pulmonary artery pressure-volume loops

Speaker: Miss C. Palacios Echavarren (Logrono, ES)

DLCO, a potential indicator of pulmonary microvasculopathy, and its association with exercise capacity, oxygenation, and hemodynamics in patients with chronic thromboembolic pulmonary hypertension aft

Speaker: Doctor Y. Yanagisawa (Tokyo, JP)

Transcollateral retrograde balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: Insights from a Japanese expert center

Speaker: Doctor N. Ikeda (Tokyo, JP)

Access the full session

Chronic thromboembolic pulmonary hypertension: management strategies

Speakers: Doctor L. Alajbegovic, Doctor Y. Taniguchi, Doctor M. Salvi, Miss C. Palacios Echavarren, Doctor Y. Yanagisawa...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources